Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ebru Ballı"'
Autor:
Simge Bardak, Kenan Turgutalp, Ebru Ballı, Banu Coşkun Yılmaz, İclal Gürses, Kaan Esen, Serap Demir, Ahmet Kıykım
Publikováno v:
Nefrología, Vol 36, Iss 5, Pp 565-567 (2016)
Externí odkaz:
https://doaj.org/article/2cd696645ccb42789f1f88672b0c5f03
Publikováno v:
Proceedings, Vol 2, Iss 25, p 1527 (2018)
Breast cancer is the leading type of cancer in women. The majority of cells in the diagnosis of breast cancer are estrogen receptor alpha (ER α) positive and the growth of these tumors is due to estrogen. Tamoxifen is used as a supportive treatment
Externí odkaz:
https://doaj.org/article/07250313f4414f84aa0232ec121571d5
Autor:
Zeynep Ebru Eser, Kenan Turgutalp, Yasemin Karabulut, Esra Akcali, Emre Cagatay Kose, Ebru Ballı, Simge Bardak, Serap Demir, Ahmet Kıykım
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Recently, prognostic importance of antibodies in primary membranous nephropathy is well defined. However, knowledge about antibodies related to disease activity in membranous lupus nephritis (MLN) is limited. Exostosin1 and exosto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd3429deb4ed63590329ec761fa9c1c6
https://doi.org/10.1093/ndt/gfac063.005
https://doi.org/10.1093/ndt/gfac063.005
Autor:
Esra Pekoglu, Belgin Buyukakilli, Cagatay Han Turkseven, Ebru Balli, Gulsen Bayrak, Burak Cimen, Senay Balci
Publikováno v:
Journal of Investigative Surgery, Vol 34, Iss 12, Pp 1329-1338 (2021)
Purpose Ischemia-reperfusion (I-R) injury is a serious problem caused by vascular trauma, tourniquet use and/or compartment syndrome. Studies have reported that skeletal muscle function is impaired due to the lower extremity I-R injury. There are ins
Externí odkaz:
https://doaj.org/article/9cdc973d2793428fbd74c24e27ef13f5
The Prevalence of Fabry Disease in Patients with Chronic Kidney Disease in Turkey: The TURKFAB Study
Autor:
Kultigin Turkmen, Aydın Guclu, Garip Sahin, Ismail Kocyigit, Levent Demirtas, Fatih Mehmet Erdur, Erkan Sengül, Oktay Ozkan, Habib Emre, Faruk Turgut, Hilmi Unal, Murat Karaman, Cengiz Acıkel, Hasan Esen, Ebru Balli, Gulfidan Bıtırgen, Halil Zeki Tonbul, Mahmut Ilker Yılmaz, Alberto Ortiz
Publikováno v:
Kidney & Blood Pressure Research, Vol 41, Iss 6, Pp 1016-1024 (2016)
Background/Aims: Fabry disease is a treatable cause of chronic kidney disease (CKD) characterized by a genetic deficiency of α-galactosidase A. European Renal Best Practice (ERBP) recommends screening for Fabry disease in CKD patients. However, this
Externí odkaz:
https://doaj.org/article/2802162750e6454aba7a669be8d59b28